Literature DB >> 28838934

Management of Cardiac Involvement Associated With Neuromuscular Diseases: A Scientific Statement From the American Heart Association.

Brian Feingold, William T Mahle, Scott Auerbach, Paula Clemens, Andrea A Domenighetti, John L Jefferies, Daniel P Judge, Ashwin K Lal, Larry W Markham, W James Parks, Takeshi Tsuda, Paul J Wang, Shi-Joon Yoo.   

Abstract

For many neuromuscular diseases (NMDs), cardiac disease represents a major cause of morbidity and mortality. The management of cardiac disease in NMDs is made challenging by the broad clinical heterogeneity that exists among many NMDs and by limited knowledge about disease-specific cardiovascular pathogenesis and course-modifying interventions. The overlay of compromise in peripheral muscle function and other organ systems, such as the lungs, also makes the simple application of endorsed adult or pediatric heart failure guidelines to the NMD population problematic. In this statement, we provide background on several NMDs in which there is cardiac involvement, highlighting unique features of NMD-associated myocardial disease that require clinicians to tailor their approach to prevention and treatment of heart failure. Undoubtedly, further investigations are required to best inform future guidelines on NMD-specific cardiovascular health risks, treatments, and outcomes.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  AHA Scientific Statements; cardiomyopathy; muscular dystrophy; neuromuscular disease; pediatrics

Mesh:

Year:  2017        PMID: 28838934     DOI: 10.1161/CIR.0000000000000526

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  55 in total

1.  Cardiac manifestations in Emery-Dreifuss muscular dystrophy.

Authors:  Whitney Faiella; Ricardo Bessoudo
Journal:  CMAJ       Date:  2018-12-03       Impact factor: 8.262

Review 2.  Pharmacology and toxicology of eteplirsen and SRP-5051 for DMD exon 51 skipping: an update.

Authors:  Omar Sheikh; Toshifumi Yokota
Journal:  Arch Toxicol       Date:  2021-11-19       Impact factor: 5.153

Review 3.  Congenital or Early Developing Neuromuscular Diseases Affecting Feeding, Swallowing and Speech - A Review of the Literature from January 1998 to August 2021.

Authors:  Lotta Sjögreen; Lisa Bengtsson
Journal:  J Neuromuscul Dis       Date:  2022

Review 4.  Neuromuscular diseases and their cardiac manifestations under the spectrum of cardiovascular imaging.

Authors:  Georgios M Alexandridis; Efstathios D Pagourelias; Nikolaos Fragakis; Maria Kyriazi; Efthymia Vargiami; Dimitrios Zafeiriou; Vassilios P Vassilikos
Journal:  Heart Fail Rev       Date:  2022-07-20       Impact factor: 4.654

5.  Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement.

Authors:  Sean M Lang; Tarek Alsaied; Philip R Khoury; Thomas D Ryan; Michael D Taylor
Journal:  Int J Cardiovasc Imaging       Date:  2020-09-20       Impact factor: 2.357

Review 6.  Restoring Protein Expression in Neuromuscular Conditions: A Review Assessing the Current State of Exon Skipping/Inclusion and Gene Therapies for Duchenne Muscular Dystrophy and Spinal Muscular Atrophy.

Authors:  Omar Sheikh; Toshifumi Yokota
Journal:  BioDrugs       Date:  2021-06-07       Impact factor: 5.807

7.  Congenital myopathies are mainly associated with a mild cardiac phenotype.

Authors:  Helle Petri; Karim Wahbi; Nanna Witting; Lars Køber; Henning Bundgaard; Emna Kamoun; Geoffroy Vellieux; Tanya Stojkovic; Anthony Béhin; Pascal Laforet; John Vissing
Journal:  J Neurol       Date:  2019-03-14       Impact factor: 4.849

8.  Somatic gene editing ameliorates skeletal and cardiac muscle failure in pig and human models of Duchenne muscular dystrophy.

Authors:  A Moretti; L Fonteyne; F Giesert; P Hoppmann; A B Meier; T Bozoglu; A Baehr; C M Schneider; D Sinnecker; K Klett; T Fröhlich; F Abdel Rahman; T Haufe; S Sun; V Jurisch; B Kessler; R Hinkel; R Dirschinger; E Martens; C Jilek; A Graf; S Krebs; G Santamaria; M Kurome; V Zakhartchenko; B Campbell; K Voelse; A Wolf; T Ziegler; S Reichert; S Lee; F Flenkenthaler; T Dorn; I Jeremias; H Blum; A Dendorfer; A Schnieke; S Krause; M C Walter; N Klymiuk; K L Laugwitz; E Wolf; W Wurst; C Kupatt
Journal:  Nat Med       Date:  2020-01-27       Impact factor: 53.440

9.  Read-through approach for stop mutations in Duchenne muscular dystrophy. An update.

Authors:  Luisa Politano
Journal:  Acta Myol       Date:  2021-03-31

Review 10.  Diagnosis of Cardiac Abnormalities in Muscular Dystrophies.

Authors:  Elisabeta Bădilă; Iulia Ioana Lungu; Alexandru Mihai Grumezescu; Alexandru Scafa Udriște
Journal:  Medicina (Kaunas)       Date:  2021-05-12       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.